The TRULICITY 1.5 MG Diaries
The trial attained both its Most important endpoints, with semaglutide two.four mg demonstrating statistically major and outstanding improvements in liver fibrosis without worsening of steatohepatitis, and resolution of steatohepatitis without any worsening of liver fibrosis in people with MASH in comparison to placebo.oneYour Mounjaro pen will be